| |
7th Peds Wk: Safety and Efficacy of Atazanavir Powder and Ritonavir Liquid in HIV-1-Infected Infants and Children Aged From 3 Months to <11 Years: the PRINCE-2 Study
|
| |
| |
Reported by Jules Levin
7th International Workshop on HIV Pediatrics, July 17-18, 2015, Vancouver, British Columbia, Canada
M. F. Cotton1, A. Liberty2, I. Torres-Escobar3, J. Lissens4, L. Zaru5, I. Klauck6, D. Cambilargiu7, C. Pikora8, T. Correll9
1Stellenbosch University, Children's Infectious Diseases Clinical Research Unit, Department of Pediatrics & Child Health, Tygerberg, South Africa;
2Chris Hani Baragwanath Hospital, HIV Research Unit, Soweto, South Africa; 3Faculty of Medicine, Benemerita Universidad Autonoma de Puebla - CAPASITS, Puebla, Mexico;
4Bristol-Myers Squibb, Braine L'Alleud, Belgium; 5Bristol-Myers Squibb, Hopewell, NJ, USA; 6Bristol-Myers Squibb, Rueil-Malmaison, France;
7Bristol-Myers Squibb, Buenos Aires, Argentina; 8Bristol-Myers Squibb, Wallingford, CT, USA; 9Bristol-Myers Squibb, Princeton, NJ, USA
|
|
| |
| |
|
|
|
